Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89201-89250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
PHASE3
Recruiting
646 participants
Started: Mar 8, 2022 · Completed: Mar 7, 2027
15 conditions
1 sponsor
40 locations
NCT05131828
CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
PHASE2
Active, not recruiting
70 participants
Started: Mar 8, 2022 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT05292274
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
N/A
Recruiting
350 participants
Started: Mar 8, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05162118
Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
51 participants
Started: Mar 8, 2022 · Completed: Dec 22, 2025
1 condition
1 sponsor
1 location
NCT05158361
Acupuncture for Overactive Bladder in Adults
NA
Recruiting
110 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05288127
Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature
PHASE2
Recruiting
55 participants
Started: Mar 8, 2022 · Completed: Nov 30, 2025
2 conditions
5 sponsors
1 location
NCT05225402
Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU
N/A
Recruiting
45 participants
Started: Mar 8, 2022 · Completed: Dec 30, 2025
3 conditions
2 sponsors
1 location
NCT05847062
Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.
NA
Recruiting
42 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05248243
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
N/A
Recruiting
41 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2025
3 conditions
1 sponsor
1 location
NCT06134297
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
NA
Enrolling by invitation
93 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05183763
Medication Adherence Program
NA
Recruiting
402 participants
Started: Mar 7, 2022 · Completed: Apr 30, 2027
3 conditions
4 sponsors
5 locations
NCT05288439
A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor
NA
Recruiting
40 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05028062
Naltrexone in AUD Reward Drinkers
PHASE4
Recruiting
60 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT05657847
Novel Complex Radiodiagnostics of Peripherial Arthropathies
N/A
Recruiting
500 participants
Started: Mar 7, 2022 · Completed: Feb 1, 2027
3 conditions
3 sponsors
3 locations
NCT04538482
DASH INtervention to INvestigate the Gut
NA
Recruiting
112 participants
Started: Mar 7, 2022 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT04881032
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2027
1 condition
2 sponsors
9 locations
NCT07158047
Repeated Far Infrared Sauna Bathing in Adults With Obesity
NA
Recruiting
20 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04920812
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases
N/A
Recruiting
66 participants
Started: Mar 7, 2022 · Completed: Sep 7, 2025
1 condition
1 sponsor
9 locations
NCT05462457
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
N/A
Recruiting
150 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2032
2 conditions
1 sponsor
1 location
NCT05215808
SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects
PHASE1
Recruiting
72 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
6 locations
NCT05144542
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
NA
Recruiting
140 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05014646
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
PHASE2
Recruiting
56 participants
Started: Mar 7, 2022 · Completed: Jul 1, 2026
1 condition
2 sponsors
4 locations
NCT06613295
Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
NA
Recruiting
128 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2027
3 conditions
1 sponsor
9 locations
NCT05166616
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
PHASE1
Recruiting
30 participants
Started: Mar 7, 2022 · Completed: Oct 28, 2027
10 conditions
2 sponsors
1 location
NCT06782802
Clinical Significance and Prognostic Value of Prenatal Diagnosis of Obliteration of the Cavum Septum Pellucidum
N/A
Recruiting
15 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05302050
A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus
NA
Active, not recruiting
500 participants
Started: Mar 7, 2022 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT04968964
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
NA
Recruiting
55 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2029
2 conditions
2 sponsors
1 location
NCT06436846
Genomic Risk in Retroperitoneal Sarcoma
N/A
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Aug 1, 2027
2 conditions
1 sponsor
1 location
NCT05183737
Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease
NA
Active, not recruiting
34 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05985447
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
N/A
Recruiting
180 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05246345
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
N/A
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2027
5 conditions
1 sponsor
14 locations
NCT05091424
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
PHASE1
Recruiting
137 participants
Started: Mar 7, 2022 · Completed: Feb 28, 2030
1 condition
1 sponsor
30 locations
NCT05132582
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
PHASE3
Active, not recruiting
654 participants
Started: Mar 7, 2022 · Completed: Sep 28, 2027
1 condition
1 sponsor
295 locations
NCT05343403
Parental Participation on the Neonatal Ward - the neoPARTNER Study
N/A
Active, not recruiting
613 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2025
15 conditions
2 sponsors
10 locations
NCT04883411
CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
NA
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
6 conditions
4 sponsors
4 locations
NCT05304767
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
PHASE3
Recruiting
280 participants
Started: Mar 7, 2022 · Completed: Mar 19, 2026
1 condition
1 sponsor
175 locations
NCT05098470
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
PHASE3
Active, not recruiting
100 participants
Started: Mar 7, 2022 · Completed: Jul 29, 2026
1 condition
2 sponsors
2 locations
NCT05118906
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
PHASE2
Active, not recruiting
66 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05261139
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
PHASE3
Recruiting
160 participants
Started: Mar 7, 2022 · Completed: Jul 30, 2026
1 condition
1 sponsor
73 locations
NCT05046860
Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
NA
Recruiting
43 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
4 locations
NCT05250908
INTIBIA Pivotal Study
NA
Active, not recruiting
208 participants
Started: Mar 7, 2022 · Completed: Jun 27, 2026
6 conditions
1 sponsor
22 locations
NCT05988450
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
NA
Active, not recruiting
125 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05052801
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
PHASE3
Active, not recruiting
547 participants
Started: Mar 7, 2022 · Completed: Jun 20, 2026
2 conditions
2 sponsors
300 locations
NCT05160506
Corticosteroids to Treat Pancreatitis
PHASE2
Recruiting
86 participants
Started: Mar 6, 2022 · Completed: Apr 30, 2027
4 conditions
1 sponsor
1 location
NCT05061862
Cardiac Implantable Electronic Device (CIED) Research Study
N/A
Recruiting
1,000 participants
Started: Mar 6, 2022 · Completed: May 1, 2026
3 conditions
1 sponsor
9 locations
NCT05781386
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
PHASE1
Recruiting
255 participants
Started: Mar 6, 2022 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT05267886
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
PHASE4
Recruiting
346 participants
Started: Mar 5, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT05215340
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
PHASE3
Recruiting
740 participants
Started: Mar 4, 2022 · Completed: Apr 30, 2028
1 condition
3 sponsors
242 locations
NCT05259982
Vital Root-resective Therapy in Furcation-involved Maxillary Molars
NA
Active, not recruiting
10 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05336084
Circadian Rhythms and Homeostatic Sleep Drive and Their Effect on Reward and Cognitive Control Systems in Adolescents
NA
Recruiting
96 participants
Started: Mar 4, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
1782
1783
1784
1785
1786
1787
1788
More pages
2369
Next